CareDx, Inc

NasdaqGM:CDNA Stock Report

Market Cap: US$1.0b

CareDx Dividends and Buybacks

Dividend criteria checks 0/6

CareDx does not have a record of paying a dividend.

Key information

n/a

Dividend yield

7.6%

Buyback Yield

Total Shareholder Yield7.6%
Future Dividend Yield0%
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

Recent updates

CareDX Has Reached An Inflection Point, But Regulatory Risks Remain (Upgrade)

Dec 22

CareDx, Inc's (NASDAQ:CDNA) Shares Bounce 25% But Its Business Still Trails The Industry

Nov 29
CareDx, Inc's (NASDAQ:CDNA) Shares Bounce 25% But Its Business Still Trails The Industry

We Believe CareDx's (NASDAQ:CDNA) Earnings Are A Poor Guide For Its Profitability

Nov 12
We Believe CareDx's (NASDAQ:CDNA) Earnings Are A Poor Guide For Its Profitability

CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 28% But Its Business Prospects Need A Lift Too

Sep 19
CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 28% But Its Business Prospects Need A Lift Too

Calculating The Intrinsic Value Of CareDx, Inc (NASDAQ:CDNA)

Aug 27
Calculating The Intrinsic Value Of CareDx, Inc (NASDAQ:CDNA)

The Market Doesn't Like What It Sees From CareDx, Inc's (NASDAQ:CDNA) Revenues Yet As Shares Tumble 32%

Jul 23
The Market Doesn't Like What It Sees From CareDx, Inc's (NASDAQ:CDNA) Revenues Yet As Shares Tumble 32%

Is There An Opportunity With CareDx, Inc's (NASDAQ:CDNA) 28% Undervaluation?

May 02
Is There An Opportunity With CareDx, Inc's (NASDAQ:CDNA) 28% Undervaluation?
User avatar

AlloMap Testing And OPTN Project Will Expand Markets Despite Risks

CareDx's growth fueled by expanded testing services and strategic investments aims to improve margins and revenue cycle management.

CareDx: Some Litigation Clouds Have Cleared

Mar 13

Why CareDx's (NASDAQ:CDNA) Earnings Are Weaker Than They Seem

Mar 11
Why CareDx's (NASDAQ:CDNA) Earnings Are Weaker Than They Seem

CareDx: Too Risky For Me

Dec 30

The Market Doesn't Like What It Sees From CareDx, Inc's (NASDAQ:CDNA) Revenues Yet As Shares Tumble 26%

Nov 05
The Market Doesn't Like What It Sees From CareDx, Inc's (NASDAQ:CDNA) Revenues Yet As Shares Tumble 26%

CareDx Resolves Key Issues: Poised For Growth In Transplant Diagnostics

Sep 29

CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 34% But Its Business Prospects Need A Lift Too

Aug 01
CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 34% But Its Business Prospects Need A Lift Too

CareDx: Benefiting From Some Certainty

Jul 15

Why Investors Shouldn't Be Surprised By CareDx, Inc's (NASDAQ:CDNA) 28% Share Price Plunge

Apr 27
Why Investors Shouldn't Be Surprised By CareDx, Inc's (NASDAQ:CDNA) 28% Share Price Plunge

CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 40% But Its Business Prospects Need A Lift Too

Mar 02
CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 40% But Its Business Prospects Need A Lift Too

CareDx, Inc's (NASDAQ:CDNA) Shares Bounce 26% But Its Business Still Trails The Industry

Dec 27
CareDx, Inc's (NASDAQ:CDNA) Shares Bounce 26% But Its Business Still Trails The Industry

CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Dec 27
CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Benign Growth For CareDx, Inc (NASDAQ:CDNA) Underpins Its Share Price

Jun 29
Benign Growth For CareDx, Inc (NASDAQ:CDNA) Underpins Its Share Price

Analyst Forecasts Just Became More Bearish On CareDx, Inc (NASDAQ:CDNA)

May 16
Analyst Forecasts Just Became More Bearish On CareDx, Inc (NASDAQ:CDNA)

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if CDNA's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CDNA's dividend payments have been increasing.


Dividend Yield vs Market

CareDx Dividend Yield vs Market
How does CDNA dividend yield compare to the market?
SegmentDividend Yield
Company (CDNA)n/a
Market Bottom 25% (US)1.4%
Market Top 25% (US)4.4%
Industry Average (Biotechs)2.4%
Analyst forecast (CDNA) (up to 3 years)0%

Notable Dividend: Unable to evaluate CDNA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CDNA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate CDNA's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as CDNA has not reported any payouts.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/24 03:41
End of Day Share Price 2025/12/24 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CareDx, Inc is covered by 14 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mark MassaroBTIG
William BonelloCraig-Hallum Capital Group LLC
Matthew SykesGoldman Sachs